GE's Healthymagination Fund is an equity fund that will invest in promising healthcare-technology companies.
The fund will invest in companies with diagnostic, IT and life-sciences technologies that are aligned with the strategic objectives of GE's Healthymagination initiative.
It will target three broad areas for investment: broad-based diagnostics, including imaging, home health, patient monitoring, molecular diagnostics, pathology, novel imaging agents and other technologies for disease diagnosis; healthcare information technology, including electronic medical records, clinical-information systems, healthcare information exchanges and value-added data services; and life sciences, including tools for research and development in biopharmaceuticals and stem cells, and technologies for manufacturing of biopharmaceuticals and vaccines.
The fund will draw on capabilities from across GE Healthcare, GE Capital and GE Global Research.
